Ontrak Shares Double As Data Shows Reduction in Depression, Anxiety Symptoms For Its Program Members

  • Ontrak Inc OTRK announced initial assessment results showing that after six months, 30% of assessed Ontrak Wholehealth+ members sustained a clinically significant reduction in anxiety symptoms, and 55% sustained a clinically significant reduction of depressive symptoms.
  • Ontrak Health is one of the only behavioral services companies to institute formal PHQ-9 (a measure of depression severity) and GAD-7 (a measure of anxiety severity) assessments to gain valuable insights into their members’ mental health care progress and support them.
  • In June 2022, Ontrak Health implemented PHQ-9 and GAD-7 assessments as foundational measurements of its care coaching model and evidence-based Wholehealth+ program. 
  • While primarily used by providers, Ontrak Health has incorporated them into its care coaching model to promote better monitoring, collaboration, and accountability with its providers and customers.
  • Thousands of assessments have been completed representing results for more than 1,000 unique program enrollees. 
  • By tracking changes in assessment scores over time, healthcare professionals can gauge the effectiveness of treatment interventions, identify issues, and take early action to address them.
  • Trending on assessment scores can help patients see progress over time. It is beneficial for patients who may have a history of chronic symptoms or are experiencing new mental health concerns. The data can provide a source of information in optimizing treatment.
  • Price Action: OTRK shares are up 111.3% at $1.2150 on the last check Wednesday.



Image and article originally from www.benzinga.com. Read the original article here.